Abstract
von Hippel Lindau disease (VHL) is an autosomal dominant hereditary disease in which the CNS and retinal hemangioblastomas, renal cell carcinoma, pheocromocytoma, abdominal cystic masses e.g. in the kidney, liver, pancreas, and epididymal cysts may develop. VHL disease manifests itself by 65 years of age. The annual incidence is 1/36,000 live births. In the brain its manifestations are in the cerebellum, brain stem, spinal cord and suprasellar hemangioblastomas and endolymphatic sac tumors.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kanno H, Yamamoto I, Nishikawa R, et al. Spinal cord hemangioblastomas in von Hippel-Lindau disease. Spinal Cord. 2009;47(6):447–52.
Mehta GU, Asthagiri AR, Bakhtian KD, Auh S, Oldfield EH, Lonser RR. Functional outcome after resection of spinal cord hemangioblastomas associated with von Hippel-Lindau disease. J Neurosurg Spine. 2010;12(3):233–42.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Eltorai, I.M. (2016). Spinal Hemangioblastomas in Von Hippel Lindau Disease. In: Rare Diseases and Syndromes of the Spinal Cord. Springer, Cham. https://doi.org/10.1007/978-3-319-45147-3_121
Download citation
DOI: https://doi.org/10.1007/978-3-319-45147-3_121
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-45146-6
Online ISBN: 978-3-319-45147-3
eBook Packages: MedicineMedicine (R0)